Stock AnalizMettler Toledo International Inc MTD
Biotechnology: Laboratory Analytical Instruments · IPO 1997 · data as of November 13, 2026
Mettler Toledo International Inc (MTD) is a industrial company listed in the US with a market value of about $34.6B. In the twelve months to September 30, 2026 it had revenue of $4.2B and net income of $934M, a net margin of 22.2%.
Its overall Stock Analiz score is 1.6 out of 5 (weak). The strongest part is shareholder returns (3/5); the weakest is value (0/5).
Key numbers: a P/E of 37.7, a price to free cash flow of 39.7, 5-year revenue growth of 5% a year. A discounted cash flow model with moderate assumptions puts its intrinsic value about 49% below the current price.
Score: 1.6 / 5
Checks passed
- Profit margin improving
- 5-year EPS growth above 10% a year
- Profitable 5 years in a row
- Positive free cash flow
- Debt below 3 years of free cash flow
- Share count down over 3 years (buybacks)
- 20% to 100% of free cash flow returned to shareholders
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.2B | $4.0B | $3.9B | $3.8B | $3.9B | $3.7B | $3.1B | $3.0B | $2.9B | $2.7B | $2.5B |
| Net income | $934M | $869M | $863M | $789M | $873M | $769M | $603M | $561M | $513M | $376M | $384M |
| Free cash flow | $871M | $849M | $864M | $861M | $738M | $801M | $632M | $506M | $422M | $389M | $337M |
| EPS (diluted) | $46.10 | $42.05 | $40.48 | $35.90 | $38.41 | $32.78 | $24.91 | $22.47 | $19.88 | $14.24 | $14.22 |
| Net margin | 22.2% | 21.6% | 22.3% | 20.8% | 22.3% | 20.7% | 19.5% | 18.6% | 17.5% | 13.8% | 15.3% |
| ROIC | — | — | — | — | — | — | — | — | — | 26.0% | 30.5% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 12 analysts is $1712.50, 2% below the current price; targets range from $1200.00 to $1930.00; the consensus rating is “Hold”; expected EPS is $47.82 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Mettler Toledo International’s P/E ratio?
About 37.7, based on the last twelve months of diluted earnings per share (forward P/E about 33.6).
Is Mettler Toledo International stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 49% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Mettler Toledo International pay a dividend?
Not currently.
Is Mettler Toledo International a good stock to buy?
We do not give buy or sell advice. Mettler Toledo International scores 1.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.